相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ALT Flare Predicts Hepatocellular Carcinoma Among Antiviral Treated Patients With Chronic Hepatitis B: A Cross-Country Cohort Study
Yanan Du et al.
FRONTIERS IN ONCOLOGY (2021)
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients
Jia-Horng Kao et al.
HEPATOLOGY INTERNATIONAL (2021)
Prediction of hepatic inflammation in chronic hepatitis B patients with a random forest-backward feature elimination algorithm
Ji-Yuan Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During Therapy
Yameng Sun et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Perioperative antiviral therapy improves the prognosis of HBV DNA-negative patients with HBV-related hepatocellular carcinoma
Chuan Li et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2020)
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2019)
KASL clinical practice guidelines for management of chronic hepatitis B
Hyung Joon Yim et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2019)
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance
James Fung et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Hepatitis B virus infection
Man-Fung Yuen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Jung Hee Kim et al.
HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up
Wei Zhang et al.
MEDICINE (2017)
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection
Mahmoud Abu-Amara et al.
GUT (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration
F. Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Approaches to inverse-probability-of-treatment-weighted estimation with concurrent treatments
Alan R. Ellis et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular Carcinoma
Chuen-Fei Chen et al.
GASTROENTEROLOGY (2011)
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study
George V. Papatheodoridis et al.
GUT (2011)
Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naive Patients with a Partial Virological Response
Roeland Zoutendijk et al.
HEPATOLOGY (2011)
Clinical Scoring System to Predict Hepatocellular Carcinoma in Chronic Hepatitis B Carriers
Vincent Wai-Sun Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Adjusted survival curves with inverse probability weights
SR Cole et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)
分享论文
